Delivery Order SPE2DB22D2007-SPE2DB23FJ2KX
- Not listed
- This federal contract award, valued at $9,072.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lotrel 10-20 mg capsules to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $1,506.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Lotrel 10-20 mg capsule, a medication used to treat high blood pressure. The contract has an ultimate completion date of December 11, 2023 and is a firm fixed-price arrangement. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award, valued at $133,534.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication, to support military and veteran healthcare programs. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The federal contract award, valued at $59,382.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order to provide the pharmaceutical product Lotrel 10-20 mg capsules, a medication used for cardiovascular health. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $15,309.96 firm-fixed-price delivery order is for the supply of Lotrel 10-20 mg capsules to support military healthcare programs. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $5,816.06 for the supply of LOTREL 10-20 MG CAPSULE 100S. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a completion date of February 17, 2022. The contract is a Firm Fixed Price type and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,634.72 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of July 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has significant Indefinite Delivery Contracts...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LOTREL 10-20 MG CAPSULE 100S. The $3,678.83 firm-fixed-price delivery order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,198.86 Firm Fixed Price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This award is a part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to...
- This federal contract award is a delivery order valued at $11,195.19 made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Lotrel 10-20 mg capsules, a cardiovascular medication, through February 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ2KXDelivery Order
This federal contract award, valued at $22,065.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Lotrel 10-20 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract has a completion date of May 16, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has received numerous contracts from the DLA Troop Support Medical, including a significant $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities worldwide. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts demonstrate Amerisourcebergen's key role in supplying essential medications and medical supplies to various federal agencies and healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.1k | 5/15/23 |